Correlation between infl ammatory markers and insulin resistance in pregnancy

Journal of Obstetrics and Gynaecology

Volumn 35, Issue 2, 2015, Pages 142-145

  Korkmazer, E ^a   Solak, N ^b  

^a GIRESUN UNIVERSITY   (Turkey)

^b Department of Gynecology and Obstetrics Maternity Hospital   (Turkey)

Author keywords

Gestational diabetes mellitus; High sensitive C reactive protein; Lipid profile; TNF

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; DYSLIPIDEMIA; FEMALE; GESTATION PERIOD; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; ATHEROSCLEROSIS; BLOOD; CROSS-SECTIONAL STUDY; METABOLISM; PREGNANCY; YOUNG ADULT;

ADULT; ATHEROSCLEROSIS; BIOMARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; PREGNANCY; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84921032064     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2014.948408     Document Type: Article

References (25)

1. Bartha JL, Gonźlez-Bugatto F , Ferńndez-Maćas R, Gonźlez-Gonźlez NL, Comino-Delgado R, Hervías-Vivancos B. 2008. Metabolic syndrome in normal and complicated pregnancies. European Journal of Obstetrics, Gynecology, and Reproductive Biology 137:178-184.
2. Chakarova N, Tankova T, Atanassova I, Dakovska L. 2009. Serum lipid and hsCRP levels in prediabetes-impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). Diabetes Research and Clinical Practice 86:56-60.
3. Coughlan MT, Oliva K, Georgiou HM, Permezel JMH, Rice GE. 2001. Glucose-induced release of tumour necrosis factor alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabetic Medicine 18:921-927.
4. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. 2005. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial: Effect of treatment of gestational diabetes on pregnancy outcomes. New England Journal of Medicine 352:2477-2486.
5. Dobísová M, Frohlich J. 2001. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clinical Biochemistry 34:583-588.
6. Faeh D, William J, Yerly P, Paccaud F, Bovet P. 2007. Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovascular Diabetology 6:32.
7. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. 2000. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47.
8. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18:499-502.
9. Guillemette L, Lacroix M, Battista MC, Doyon M, Perron P, Hivert MC. 2013. Higher levels of tumor necrosis factor alpha are associated with insulin resistance during pregnancy and increased risk of gestational diabetes. Canadian Journal of Diabetes 37:58-62.
10. Herrera E. 2000. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. European Journal of Clinical Nutrition 54:47.
11. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. 1994. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proceedings of the National Academy of Sciences USA 91:4854-4858.
12. Kim C, Newton KM, Knopp RH. 2002. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862-1868.
13. King H. 1998. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 21:9-13.
14. Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. 2007. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. Journal of Hepatology 47:142-156.
15. Leipold H, Worda C, Gruber CJ, Prikoszovich T, Wagner O, Kautzky-Willer A. 2005. Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester. European Journal of Clinical Investigation 35:752-757.
16. Lou Y, Wu C, Wu M, Xie C, Ren L. 2014. The changes of neutrophil gelatinase- associated lipocalin in plasma and its expression in adipose tissue in pregnant women with gestational diabetes. Diabetes Research and Clinical Practice 104:136-142.
17. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P et al.; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. 2010. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676-682.
18. Montelongo A, Lasuncín MA, Pallardo LF, Herrera E. 2008. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Molecular Reproduction and Development 75:1054-1062.
19. National Cholesterol Education Program (NCEP). 2001. Expert panel on the detection, evaluation and the treatment of high blood cholesterol in adults (Adults Treatment Panel III). Journal of the American Medical Association 285:2486-2497.
20. Opie LH, Knuuti J. 2009. The adrenergic-fatty acid load in heart failure. Journal of the American College of Cardiology 54:1637-1646.
21. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. 2001. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 286:327-334.
22. Ridker PM, Hennekens CH, Buring JE, Rifai N. 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine 342:836-843.
23. Vitoratos N, Kassanos D, Salamalekis E, Siristatidis Ch, Baimacou E, Creatsas G. 2002. Maternal homocysteine levels and plasma lipids in gestational diabetes: is there any relationship? Journal of Obstetrics and Gynaecology 22:366-369.
24. Yuan G, Zhou L, Tang J, Yang Y, Gu W, Li F et al. 2006. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Research and Clinical Practice 72:244-250.
25. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. 1999. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology 19:972-978.